LSD Trial Study Shows Potential For Major Depression

• Psychedelics biopharma companyMind Medicine Inc.(NASDAQ:MNMD) recently shared positive topline data from an advanced clinical trial of LSDas a treatment of Major Depressive Disorder (MDD).
• The double-blind Phase 2 study demonstrated "significant, rapid, durable and beneficial effects" on the mitigation of MDD symptoms.Read more HERE.

Canada's Large Scale Psilocybin Macrodose Trial

• Canadian biopharma companyApex Labs Ltd.,has received Health Canada's approval for a comprehensive, "statistically powered" macro-and-multi dose advanced psilocybin trial on 160 patients.
• The trial's primary indication (severe depression within PTSD) is...